MPLN (@molpathnet) header
MPLN (@molpathnet) profile picture

MPLN

@molpathnet

Molecular Pathology Laboratory Network, custom services for #oncologists #pathologists; experience in #flowcytometry #cytogenetics #FISH #molecular #genomics

 Maryville, TN
mplnet.com
Joined March 2016
  • Tweets264
  • Following85
  • Followers89
4Media
Photo by MPLN (@molpathnet)Photo by MPLN (@molpathnet)Photo by MPLN (@molpathnet)Photo by MPLN (@molpathnet)
Learn about a HER2 testing in gastric cancer guideline from @Pathologists, ASCP, & @ASCO. youtu.be/4wXc_WpeQGE #strongertogether
3
1
4
Therapy-related #myelofibrosis does not appear to exist buff.ly/2s0wjp4 via @BloodAdvances
7
4
A new study found that U.S. cancer mortality rates are falling, but some regions have been left behind: sm.aacr.org/fRrv309hNma via @theNCI
Image from AACR Foundation (@AACRFoundation)
9
3
7
Pembrolizumab approved 1st line in Europe for NSCLC. Reflex PDL1 testing is a priority for UK @BTOGORG @IASLC #LCSM mercknewsroom.com/news-relea…
2
4
1
PW: Need to get away from notion of sequencing a cancer once and for all as cancers will change. Need #bigdata approaches #GenomicsFest
2
10
1
9
New #ASCOU Leukemia Molecular Oncology Tumor Board is live! Interact with experts & join the discussion today. ow.ly/CMsC30925oT
4
3
Review: Acute Myeloid #Leukemia Targets for Bispecific Antibodies ow.ly/bE9Q308Mkpm
Image from Hematopoiesis News (@Hema_News)
2
1
Pubmed: Comprehensive analysis of PD-L1 expression in glioblastoma multiforme. dlvr.it/NKm7lJ
1
1
CMS Proposes Inclusion of Cologuard in Medicare Advantage Star Ratings exas.co/2kll2Jo $EXAS
4
7
Important to recognise that the private sector is making a bigger commitment to the North's health science economy than people know nitter.gq/edcox_ippr/status/8009…
Ed Cox (@edcox_devo) profile pictureEd Cox@edcox_devo22 Nov 2016
Govt must match private investment in health R&D to unlock Northern potential < new @IPPRNorth @The_NHSA report ippr.org/publications/health…
6
5
Read the latest supplement from Annals bit.ly/2e2iM6V The ALK story: from biology to personalised medicine #NCSLC #lungcancer
4
4
Geneuity and @molpathnet now offers SP263 PD-L1 testing; #Atezolizumab in Urothelial Carcinoma : Phase 2 Trial. jurology.com/article/S0022-5…
1
Don't fall behind. The standard of care for advanced NSCLC is set to change in the next few months (w/need to test PDL1 in all)-Corey Langer
Image from Drew Moghanaki (@DrewMoghanaki)
Image from Drew Moghanaki (@DrewMoghanaki)
Image from Drew Moghanaki (@DrewMoghanaki)
5
2
PD-1 inhibitor nivolumab safe in early #lungcancer goo.gl/gqNY4G #lcsm
3
#mmpathic is looking forward to working with the BRC team going forward #brc nitter.gq/UoMStaffNet/status/775…
UoM StaffNet (@UoMStaffNet) profile pictureUoM StaffNet@UoMStaffNet14 Sep 2016
£28.5m invested in Manchester’s devolved health system and lifesaving research @OfficialUoM ow.ly/mKBO304ccP9
Image from UoM StaffNet (@UoMStaffNet)
1
Data from KEYNOTE-087 study showed ORRs of ~70-80% in 3 cohorts of relapsed/refractory Hodgkin lymphoma patients targetedonc.com/news/pembrol…
5
2
Survivors of AML produce antibodies that kill leukemia cells following allogeneic HSCT that can treat AML patients targetedonc.com/news/antibod…
4
1
6
Push for molecular profiling could transform advanced #bladdercancer care goo.gl/9iMLi4
1
1
Register for #webinar: #Archer #FusionPlex, #VariantPlex for #bloodcancer mutation detection bit.ly/29C5mLV
Image from ArcherDX, Inc. (@archerdxinc)
1
1
Just announced! @molpathnet to offer @archerdxinc #FusionPlex #Sarcoma #NGS assays to #biopharma
1
1
1
1
Load more